Here, we investigated the molecular basis of NRF2/NOTCH crosstalk deregulation by KEAP1 in SCLC and evaluated its impact on impairing responses to conventional chemotherapies and NOTCH inhibitors. The gene discussed is NFE2L2; the disease is small cell lung carcinoma.